FREE Shipping on all US Orders
When the immune system turns on your hair: autoimmune conditions, hair loss mechanisms, and what a 2025 gut-skin discovery changes about how we investigate alopecia areata.
Autoimmune conditions cause hair loss through five distinct mechanisms. A paper published August 25, 2025 (JAAD, UCI) found an unexpected connection between microscopic colitis and alopecia areata — with young AA patients showing undiagnosed gut disease. The celiac-AA association is well established. The IBD-hair connection operates through nutritional deficiency and systemic inflammation. Hashimoto's is the most common cause of reversible autoimmune hair loss. Here is the complete guide.
The phrase "autoimmune hair loss" covers five completely different mechanisms. Alopecia areata is the immune system attacking the follicle directly. Lupus-related hair loss is the immune system creating systemic inflammation that pushes follicles into telogen. Hashimoto's hair loss is the immune system disrupting thyroid function that regulates the hair cycle. Each requires a different investigation, a different treatment approach, and a different prognosis. The mechanism determines everything.
In brief: Autoimmune conditions cause hair loss through five distinct mechanisms — direct follicle attack, systemic inflammation-driven telogen effluvium, hormone disruption, medication side effects, and scarring from cutaneous autoimmune lesions. A paper published August 25, 2025 in JAAD (University of California, Irvine) described an unexpected connection between microscopic colitis and alopecia areata in young patients — suggesting the gut-skin axis is more directly relevant to AA than previously understood. Hashimoto's thyroiditis is the most common cause of reversible autoimmune hair loss. Here is the complete guide to each mechanism, what it means for investigation, and what determines reversibility.
Several autoimmune diseases can cause hair loss, including alopecia areata, lupus, Hashimoto's disease, rheumatoid arthritis, scalp psoriasis, and Crohn's disease. These conditions lead to excessive shedding either directly by targeting hair follicles or indirectly through systemic inflammation, medication effects, or hormonal disruptions.
The phrase "autoimmune hair loss" is used to describe five completely different biological events. Getting the mechanism right determines both the investigation and the treatment — and in some cases, the difference between reversible and permanent loss.
Mechanism 1 — Direct follicle attack: alopecia areata
Alopecia areata (AA) is the condition most people mean when they say "autoimmune hair loss." It is the only hair loss condition in which the immune system directly attacks the hair follicle — specifically, the immune privilege of the follicle is disrupted, allowing T-cells to recognise and attack follicle antigens. The series covered AA in depth in an earlier article, so this section focuses on the new 2025 finding.
A letter published in JAAD on August 25, 2025 (Hirpara et al., University of California, Irvine) describes a pattern that was not previously well-characterised: at the authors' institution, they observed an unexpected pattern of young AA patients with a history of abdominal pain, bloating, and diarrhea since childhood without a clear diagnosis. When these patients were evaluated gastroenterologically, several were found to have microscopic colitis — a form of inflammatory bowel disease that does not show structural changes on colonoscopy but produces significant colonic inflammation on biopsy. Keywords: alopecia areata, celiac disease, collagenous colitis, Crohn's disease, eosinophilic esophagitis, lymphocytic colitis, microscopic colitis, ulcerative colitis.
This finding extends the gut-skin-hair axis that has been gaining attention. The celiac disease-AA association is well-established — people with AA are significantly more likely to have celiac disease than the general population, and AA can be the presenting manifestation of undiagnosed celiac. The microscopic colitis finding suggests the gut-AA connection may be broader than celiac alone, encompassing the wider spectrum of inflammatory bowel conditions.
The practical implication: in young AA patients with unexplained GI symptoms, gastroenterological evaluation is warranted. This is not routine currently — the 2025 paper's value is in flagging that the symptom overlap may be more common than recognised.
Mechanism 2 — Systemic inflammation-driven telogen effluvium: lupus, RA, IBD
Systemic autoimmune conditions with high inflammatory burden — systemic lupus erythematosus (SLE), rheumatoid arthritis, inflammatory bowel disease — cause diffuse hair loss through a different mechanism: not direct follicle attack, but the systemic inflammatory environment pushing large numbers of follicles into telogen simultaneously.
SLE can cause diffuse non-scarring shedding during flares from systemic inflammation, scarring hair loss from discoid LE lesions that permanently destroy the follicle, and telogen effluvium triggered by lupus medications. The scarring form is the most urgent. The distinction between SLE's non-scarring diffuse TE (reversible when inflammation is controlled) and discoid lupus lesions on the scalp (producing permanent scarring) is critical — they can coexist in the same patient.
For IBD: Crohn's disease and inflammatory bowel disease are gut disorders, but both conditions are linked to hair loss. According to a 2015 study of over 150 IBD patients, around one-third reported hair loss. The mechanism may include nutritional deficiencies from malabsorption, systemic inflammation, and medication side effects. The malabsorption component is particularly relevant — iron, zinc, vitamin D, and B12 are all preferentially absorbed in intestinal segments that IBD commonly affects. What presents as hair loss in an IBD patient may be primarily a nutritional deficiency secondary to the gut disease rather than a direct inflammatory mechanism.
Mechanism 3 — Hormone disruption: Hashimoto's and Graves' disease
Hashimoto's thyroiditis and Graves' disease are autoimmune conditions targeting the thyroid — but their hair loss operates through thyroid hormone disruption rather than follicle attack. This makes them fundamentally different from AA and closer to the nutritional and hormonal hair loss mechanisms covered extensively in this series.
Hashimoto's is the most common cause of hypothyroidism and is itself autoimmune. Thyroid hormones are essential for normal hair cycle regulation — both hypothyroidism and hyperthyroidism cause diffuse telogen effluvium. Hair loss from Hashimoto's is typically diffuse and is one of the most treatable causes of autoimmune hair loss.
The August 2 thyroid article in this series covered Hashimoto's in detail — including the October 2025 Diseases study finding that TSH and free T4 were significantly lower in women with hair loss vs controls, both within normal range. The autoimmune component of Hashimoto's adds the TPO antibody consideration: positive TPO antibodies indicate active immune attack on the thyroid even when hormone levels appear normal, and the resulting thyroid dysfunction drives hair loss through the same anagen shortening mechanism as non-autoimmune hypothyroidism.
The distinction from AA: Hashimoto's hair loss is diffuse, not patchy. The follicles are not being attacked — they are cycling abnormally because the hormonal signal that regulates them is disrupted. When thyroid function is restored to optimal levels, hair loss from Hashimoto's typically reverses — making it one of the most treatable forms of autoimmune-associated hair loss.
Mechanism 4 — Medication-induced telogen effluvium
Many medications used to treat autoimmune conditions cause hair loss as a side effect — a second mechanism layered on top of the disease-related mechanism. This is clinically important because it can be misinterpreted as worsening disease when the disease itself may be improving.
Methotrexate causes hair loss through its anti-folate mechanism — it inhibits folate metabolism, which affects the rapidly dividing cells of the hair matrix alongside its intended immune-modulating effect. The hair loss is typically diffuse, dose-dependent, and often improves with dose reduction or folate supplementation. It is a treatment side effect, not the autoimmune disease worsening.
Hydroxychloroquine occasionally causes hair loss or hair pigment changes. The mechanism is less clearly established than methotrexate's. It is also used as a treatment for FFA (covered in yesterday's article) — the same drug causing hair loss in some autoimmune contexts while treating it in another reflects the complex and condition-specific nature of drug-hair interactions.
A paradox in autoimmune treatment: some biologics used to treat autoimmune conditions (TNF-alpha inhibitors like adalimumab, etanercept) can paradoxically trigger alopecia areata as a new-onset condition, or worsen existing AA. This is thought to reflect immune pathway redirection — suppressing one immune pathway can allow another to become overactive. New-onset patchy hair loss in a patient starting a biologic warrants evaluation for AA as a treatment side effect.
Mechanism 5 — Scarring from cutaneous autoimmune lesions
Several autoimmune conditions produce skin lesions that, when they occur on the scalp, cause permanent scarring hair loss through direct destruction of follicle tissue — the same mechanism as FFA and CCCA, but with an autoimmune rather than idiopathic or inflammatory origin.
Discoid lupus erythematosus (DLE) — a cutaneous form of lupus — produces disc-shaped plaques on the scalp that scar when active and healed. People with lupus may lose their hair in patches or more evenly. This loss may be reversible with treatment, although scarring of the scalp can sometimes prevent regrowth. The early active phase of DLE on the scalp is treatable — the scarring that follows established lesions is not reversible. This creates the same urgency principle as FFA: early identification and treatment stops further permanent loss.
What blood tests should you request if autoimmune hair loss is suspected?
The August 19 blood test guide covers the complete Tier 1 and Tier 2 panels. For autoimmune-specific investigation, add these to the standard hair loss panel:
ANA (antinuclear antibody) — lupus screen
A positive ANA is non-specific but warrants follow-up with anti-dsDNA and anti-Smith antibodies if SLE is clinically suspected. Relevant for women with diffuse hair loss plus fatigue, joint pain, photosensitivity, or rash.
tTG-IgA and total IgA — celiac screen
Tissue transglutaminase IgA is the primary celiac screen. Total IgA is essential alongside — IgA deficiency produces a false negative tTG-IgA. The celiac-AA association and the celiac-nutritional deficiency connection both make this test relevant for diffuse shedding and patchy AA. Must be performed while eating gluten — a gluten-free diet normalises the test and misses the diagnosis.
TPO antibodies and thyroglobulin antibodies — Hashimoto's specific
Already in the standard thyroid panel from August 19 — but worth emphasising here as the most common autoimmune cause of hair loss. TPO antibodies can be positive years before TSH becomes abnormal. Their presence indicates active immune attack on the thyroid even when hormone levels currently appear normal.
B12, folate, zinc — in IBD, celiac, or malabsorption context
When IBD or celiac is known or suspected, the nutritional deficiency panel expands beyond ferritin and vitamin D to include B12, folate, and zinc — all preferentially absorbed in gut segments commonly affected by these conditions. High MCV on CBC suggests B12 or folate deficiency rather than iron deficiency as the anaemia driver.
Frequently Asked Questions
Do autoimmune diseases cause hair loss?
Yes — through five distinct mechanisms. Alopecia areata involves the immune system directly attacking hair follicles. Lupus, RA, and IBD cause diffuse shedding through systemic inflammatory burden. Hashimoto's and Graves' disease cause hair loss through thyroid hormone disruption. Celiac disease causes hair loss through nutritional malabsorption. And several autoimmune medications cause hair loss as a side effect. The mechanism determines the treatment approach and the prognosis.
Is autoimmune hair loss reversible?
It depends entirely on the mechanism. Hashimoto's-related hair loss — among the most reversible when thyroid is optimised. Celiac disease hair loss — reverses on strict gluten-free diet. Diffuse TE from lupus flares — reverses when inflammation controlled. Alopecia areata — variable, partially reversible with treatment. Scarring from discoid lupus or FFA — permanent in scarred areas. The five mechanisms have five different reversibility profiles.
What is the connection between celiac disease and hair loss?
Two connections: nutritional malabsorption (iron, zinc, B12, folate from villous atrophy causing deficiency-driven TE) and a direct AA association (people with AA have significantly higher celiac prevalence than the general population, and celiac can present as AA before gut symptoms are prominent). Both connections make celiac screening (tTG-IgA while eating gluten) appropriate in AA patients — particularly those with any GI symptoms.
What did the 2025 gut-skin hair study find?
A paper published August 25, 2025 in JAAD (Hirpara et al., UCI) found that young alopecia areata patients presenting with unexplained GI symptoms since childhood were found on gastroenterological evaluation to have microscopic colitis — a form of IBD not visible on standard colonoscopy but confirmed on biopsy. This suggests the gut-AA connection may extend beyond the established celiac association to include broader gut inflammatory conditions. Clinically: in young AA patients with GI symptoms, gastroenterological evaluation is worth requesting.
How do I know if my hair loss is autoimmune?
Pattern and context are the first clues. Patchy, circumscribed hair loss with smooth scalp = suspect AA. Diffuse loss alongside other systemic symptoms (fatigue, joint pain, GI symptoms) = consider systemic autoimmune condition. Diffuse loss with known or suspected thyroid dysfunction = Hashimoto's or Graves'. Blood tests — ANA, tTG-IgA, TPO antibodies, plus the standard Tier 1 panel from August 19 — and trichoscopy by a dermatologist are the investigation tools. No blood test alone diagnoses autoimmune hair loss — clinical context and dermatological examination are essential.
The honest summary.
Autoimmune hair loss is not a single condition — it is five different biological events sharing the label "autoimmune." Understanding which mechanism is operating determines everything that follows: the blood tests to request, the specialist to see, the prognosis for reversibility, and whether urgency is required (scarring mechanisms) or patience is appropriate (hormone disruption, nutritional malabsorption).
The 2025 gut-skin-hair finding adds a new dimension to AA investigation that wasn't on most clinicians' radar. The celiac-AA connection was established; the microscopic colitis connection is newer and warrants awareness. For young AA patients with unexplained GI symptoms, the gut is now part of the investigation.
If you have hair loss alongside any systemic symptoms — fatigue, joint pain, GI complaints, cold intolerance, photosensitivity — the standard hair-only investigation is insufficient. The systemic context is diagnostic information. Use it.
Autoimmune hair loss is a category — not a diagnosis.
Anti-inflammatory botanical care — while the investigation runs.
Whatever systemic autoimmune driver is being investigated, the daily ritual addresses the scalp inflammatory environment that all autoimmune mechanisms amplify. Anti-inflammatory botanicals reduce the local inflammatory substrate — supporting the scalp while the systemic investigation and treatment proceed.
→ Explore the Stress Collection → Find Your FormulaScience, ritual, and botanical intelligence — delivered daily.
Each morning, one article. New research, ancient wisdom, and the honest science of hair and scalp health. Written for women who want to understand what is happening — not just what to buy.
By subscribing you agree to receive email from Laritelle Organic. Unsubscribe at any time.